Invesaro

Stocks GFF Financial statements

Financial statements

GRIFFON CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data GRIFFON CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,4771,5251,9782,2092,0672,2712,8482,6852,6242,520
Cost of revenue1,0761,1171,4671,3571,4831,6301,9121,7361,6041,462
Gross profit4014085115175846419379491,0201,058
Selling, general and administrative318341419408444471609643622608
Operating expenses3183394444711,126752622852
Operating income82.36792.8109140171-189197398206
Interest expense49.951.565.668.366.563.284.410110496
Interest income0.070.061.70.80.750.440.222.092.432.16
Other non-operating income-50.1-50.3-59-62.3-72.1-60.6-81.8-84.2-102-78.9
Pre-tax income32.216.733.846.267.5110-271113297127
Income tax12.4-1.090.5620.82639.716.835.186.876.3
Income from continuing operations19.817.833.325.541.470.3-28877.6210
Net income3014.912637.353.479.2-19277.621051.1
EBITDA129115149160192223-124240436246
EPS, basic0.730.363.060.911.251.56-3.711.494.411.13
EPS, diluted0.680.352.960.871.191.48-3.711.424.231.09
Shares, basic (weighted)41.1414140.942.650.851.752.147.645.4
Shares, diluted (weighted)44.14342.442.94553.451.754.649.746.7
Dividend per share0.200.240.280.290.300.320.360.45

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents72.647.769.872.421824912010311499
Receivables184208281264278295362312313197
Inventory261299398442320473669507425172
Other current assets23.440.142.140.841.57662.557.161.642.1
Total current assets7811,0989139251,1061,3691,2159819291,246
Property, plant and equipment237232342337297290295279288196
Lease right-of-use assets15414518317017153
Goodwill306319439419424426336328329191
Intangible assets198205371357354350762635619364
Other non-current assets7.5716.116.415.826.521.621.621.730.426.2
Total assets1,7821,8742,0852,0752,4492,6052,8162,4192,3712,076
Accounts payable14818423425117326019511711957.7
Accrued liabilities84.183.3139125144145172193182115
Deferred revenue26.324.4
Short-term debt13.911.11310.59.9212.512.79.638.168.03
Total current liabilities318371393390442532424359349446
Long-term debt8979681,1081,0941,0371,0331,5611,4601,5161,404
Lease liabilities13111915914714740.5
Other non-current liabilities123133107110122110191133131111
Total liabilities1,3711,4751,6101,5971,7481,7982,3392,1042,1462,002
Total debt9119791,1211,1041,0471,0461,5741,4701,5241,412
Paid-in capital530487503519583602628663677690
Retained earnings476480551569608670344282461479
Treasury stock-502-489-535-536-413-417-420-578-877-1,044
Other comprehensive income-81.2-60.5-34.1-65.9-72.1-46-82.7-70-58-71.9
Shareholders' equity41139947447870080747831522574
Total equity41139947447870080747831522574
Total liabilities and equity1,7821,8742,0852,0752,4492,6052,8162,4192,3712,076
Shares outstanding45.746.856.156.657.153.148.346.3

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income3014.912637.353.479.2-19277.621051.1
Depreciation and amortization46.347.955.851.552.152.364.743.137.939.7
Stock-based compensation10.18.0919.615.917.620.133.141.126.825.5
Deferred income tax6.042.34-17.6-5.472.1213.8-56.7-37.83.57-28.5
Change in receivables-35.9-19.12.6813.4-72.5-7-20.751.14.2418.9
Change in inventory16.1-29.3-52.1-31.823.3-155-10712973.6-18.3
Change in payables4.8317.511.119.640.472.8-96.4
Cash from operations80.149.258.290.310769.859.2432380357
Capital expenditures-59.3-34.9-50.1-34.9-41.2-37-42.5-63.6-68.4-52.4
Acquisitions-4.47-34.7-431-9.22-10.5-2.24-8510-14.60
Cash from investing-62.3-71.32.57-64.1-51.5-56.2-583-45.2-65-34.4
Debt issued3022334432021,24020.91,05912321763
Debt repaid-209-170-301-218-1,309-27.8-511-222-169-179
Stock issued000017800
Share buybacks-65.3-15.8-45.6-1.48-7.48-3.36-10.9-164-310-183
Dividends paid-8.8-10.3-49.8-13.7-14.5-17.1-127-134-35.8-39.7
Cash from financing15.4-0.739.1-3568.2-28.2393-400-299-339
Exchange rate effect0.890.161.170.312.38-3.54-5.4-0.69-1.971.63
Net change in cash20.6-24.922.12.6214630.6-128-17.311.5-15.4
Free cash flow20.814.28.0555.565.732.916.8368312305
Interest paid43.248.159.863.663.160.878.399.810192.9
Income taxes paid3.432132.125.32141.280.370.910396.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $98.39 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin41.4%Gross profit / revenue.
Operating margin17.6%Operating income / revenue.
EBITDA margin19.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin14.9%Pre-tax income / revenue.
Net margin7.0%Net income / revenue.
FCF margin11.6%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin13.3%Cash from operations / revenue.
Effective tax rate40.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)138.6%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)9.7%Net income / average total assets.
Return on invested capital (ROIC)21.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue25.5%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.7%Capital expenditures / revenue.
D&A / revenue1.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-3.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-4.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y4.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y3.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y4.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y12.6%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-48.2%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 5y8.1%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-43.6%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y5.1%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-75.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y-0.9%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-74.2%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y-1.7%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-5.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y82.1%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y27.3%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-2.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y163.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y35.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-67.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-46.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-36.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-12.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-9.7%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-3.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-6.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-3.3%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.41xCurrent assets / current liabilities.
Quick ratio1.04x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.37x(Cash + short-term investments) / current liabilities.
Debt / equity9.81xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets69.0%Total debt / total assets.
Liabilities / assets93.0%Total liabilities / total assets.
Net debt$1.16BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.33xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage5.15xOperating income / interest expense.
Working capital$423.4MCurrent assets - current liabilities.
Goodwill and intangibles / assets29.3%(Goodwill + intangible assets) / total assets.
Tangible book value-$408.9MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.40xRevenue / average total assets.
Fixed asset turnover12.5xRevenue / average property, plant and equipment.
Inventory turnover8.83xCost of revenue / average inventory.
Days inventory41 days365 x average inventory / cost of revenue.
Receivables turnover12.7xRevenue / average receivables.
Days sales outstanding29 days365 x average receivables / revenue.
Days payables20 days365 x average accounts payable / cost of revenue.
Cash conversion cycle50 daysDays inventory + days sales outstanding - days payables.
FCF conversion166.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow12.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.96Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$56.78Revenue / diluted weighted shares.
FCF per share$6.58Free cash flow / diluted weighted shares.
Operating cash flow per share$7.55Cash from operations / diluted weighted shares.
Book value per share$2.84Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$8.99Tangible book value / shares outstanding.
Cash per share$2.43(Cash + short-term investments) / shares outstanding.
Payout ratio21.8%Dividends paid / net income, when net income is positive.
Dividends / FCF13.1%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF47.3%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$4.46BShare price x shares outstanding.
Enterprise value$5.61BMarket cap + total debt - cash - short-term investments.
P/E24.9xMarket cap / net income. Only when net income is positive.
P/S1.74xMarket cap / revenue.
P/B34.5xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF15.0xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF13.1xMarket cap / cash from operations, when positive.
EV/Sales2.19xEnterprise value / revenue.
EV/EBIT12.4xEnterprise value / operating income, when both are positive.
EV/EBITDA11.3xEnterprise value / EBITDA, when both are positive.
EV/FCF18.9xEnterprise value / free cash flow, when both are positive.
FCF yield6.7%Free cash flow / market cap.
Earnings yield4.0%Net income / market cap (the inverse of P/E).
Dividend yield0.9%Dividends paid over the period / market cap.
Shareholder yield4.0%(Dividends paid + share buybacks) / market cap.
What was GRIFFON CORP's revenue in fiscal 2025?

GRIFFON CORP reported revenue of $2.52B for fiscal 2025, 3.9% lower than the year before.

Was GRIFFON CORP profitable in fiscal 2025?

Yes. Net income was $51.1M, a net margin of 2%.

How much free cash flow did GRIFFON CORP generate in fiscal 2025?

Cash from operations of $357.4M minus capital expenditures of $52.4M left free cash flow of $305.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to GRIFFON CORP